The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Chronic Renal Failure after Transplantation of a Nonrenal Organ
Open accessAbstract
BACKGROUND: Transplantation of nonrenal organs is often complicated by chronic renal disease with multifactorial causes. We conducted a population-based cohort analysis to evaluate the incidence of chronic renal failure, risk factors for it, and the associated hazard of death in recipients of nonrenal transplants. METHODS: Pretransplantation and post-transplantation clinical variables and data from a registry of patients with end-stage renal disease (ESRD) were linked in order to estimate the cumulative incidence of chronic renal failure (defined as a glomerular filtration rate of 29 ml per minute per 1.73 m2 of body-surface area or less or the development of ESRD) and the associated risk of death among 69,321 persons who received nonrenal transplants in the United States between 1990 and 2000. RESULTS: During a median follow-up of 36 months, chronic renal failure developed in 11,426 patients (16.5 percent). Of these patients, 3297 (28.9 percent) required maintenance dialysis or renal transplantation. The five-year risk of chronic renal failure varied according to the type of organ transplanted - from 6.9 percent among recipients of heart-lung transplants to 21.3 percent among recipients of intestine transplants. Multivariate analysis indicated that an increased risk of chronic renal failure was associated with increasing age (relative risk per 10-year increment, 1.36; P<0.001), female sex (relative risk among male patients as compared with female patients, 0.74; P<0.001), pretransplantation hepatitis C infection (relative risk, 1.15; P<0.001), hypertension (relative risk, 1.18; P<0.001), diabetes mellitus (relative risk, 1.42; P<0.001), and postoperative acute renal failure (relative risk, 2.13; P<0.001). The occurrence of chronic renal failure significantly increased the risk of death (relative risk, 4.55; P<0.001). Treatment of ESRD with kidney transplantation was associated with a five-year risk of death that was significantly lower than that associated with dialysis (relative risk, 0.56; P=0.02). CONCLUSIONS: The five-year risk of chronic renal failure after transplantation of a nonrenal organ ranges from 7 to 21 percent, depending on the type of organ transplanted. The occurrence of chronic renal failure among patients with a nonrenal transplant is associated with an increase by a factor of more than four in the risk of death.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chobanian, A. V. (2003) · JAMA · doi:10.1001/jama.289.19.2560 · Cited by 25,386
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
J Heart Lung Transplant 2021;40(4).
(2021) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2021.04.002 · Cited by 6,665
Wolfe, R. A., Ashby, V. B., Milford, E. L., Ojo, A. O., Ettenger, R. E., Agodoa, L. Y. C., Held, P. J., & Port, F. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912023412303 · Cited by 5,371
Self-citationA Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Doqi, K. (2002) · American Journal of Kidney Diseases · Cited by 1,285
Cyclosporine-Associated Chronic Nephropathy
Myers, B. D., Ross, J., Newton, L., Luetscher, J., & Perlroth, M. (1984) · New England Journal of Medicine · doi:10.1056/nejm198409133111103 · Cited by 1,144
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
Port, F. K. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510110079036 · Cited by 825
Self-citationShlipak, M. G., Heidenreich, P. A., Noguchi, H., Chertow, G. M., Browner, W. S., & McClellan, M. B. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-7-200210010-00006 · Cited by 559
Nair, S., Verma, S., & Thuluvath, P. J. (2002) · Hepatology · doi:10.1053/jhep.2002.33160 · Cited by 540
(2002) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(02)70081-4 · Cited by 532
Montori, V. M., Basu, A., Erwin, P. J., Velosa, J. A., Gabriel, S. E., & Kudva, Y. C. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.583 · Cited by 528
Role of aldosterone in the remnant kidney model in the rat.
Greene, E. L., Kren, S., & Hostetter, T. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118867 · Cited by 479
Chronic cyclosporine nephropathy: The Achilles' heel of immunosuppressive therapy
Bennett, W. M., DeMattos, A., Meyer, M. M., Andoh, T., & Barry, J. M. (1996) · Kidney International · doi:10.1038/ki.1996.415 · Cited by 436
Silvestre, J.-S., Heymes, C., Oubénaïssa, A., Robert, V., Aupetit-Faisant, B., Carayon, A., Swynghedauw, B., & Delcayre, C. (1999) · Circulation · doi:10.1161/01.cir.99.20.2694 · Cited by 380
Myers, P. D. B. D. (1986) · Kidney International · doi:10.1038/ki.1986.280 · Cited by 325
Gonwa, T. A., Jennings, L., Mai, M. L., Stark, P. C., Levey, A. S., & Klintmalm, G. B. (2004) · Liver Transplantation · doi:10.1002/lt.20017 · Cited by 313
CHRONIC RENAL FAILURE FOLLOWING LIVER TRANSPLANTATION: A Retrospective Analysis
Fisher, N. C., Nightingale, P. G., Gunson, B. K., Lipkin, G. W., & Neuberger, J. M. (1998) · Transplantation · doi:10.1097/00007890-199807150-00010 · Cited by 302
Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies
Olyaei, A. J., de Mattos, A. M., & Bennett, W. M. (2001) · Current Opinion in Critical Care · doi:10.1097/00075198-200112000-00003 · Cited by 291
Hyperlipidemia in patients with chronic renal disease
Kasiske, B. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9820472 · Cited by 281
Pathogenesis of cyclosporine nephropathy: roles of angiotensin II and osteopontin.
Pichler, R. H., Franceschini, N., Young, B. A., Hugo, C., Andoh, T. F., Burdmann, E. A., Shankland, S. J., Alpers, C. E., Bennett, W. M., & Couser, W. G. (1995) · Journal of the American Society of Nephrology · doi:10.1681/asn.v641186 · Cited by 256
Patient survival after renal transplantation; more than 25 years follow-up
Arent, S., Mallat, M., Westendorp, R., van der Woude, F., & van Es, L. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.8.1672 · Cited by 232
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation
Trompeter, R., Filler, G., Webb, N. J. A., Watson, A. R., Milford, D. V., Tyden, G., Grenda, R., Janda, J., Hughes, D., Ehrich, J. H. H., et al. (2002) · Pediatric Nephrology · doi:10.1007/s00467-001-0795-9 · Cited by 227
NEPHROTOXICITY FOLLOWING ORTHOTOPIC LIVER TRANSPLANTATION
Platz, K.-P., Mueller, A. R., Blumhardt, G., Bachmann, S., Bechstein, W.-O., Kahl, A., & Neuhaus, P. (1994) · Transplantation · doi:10.1097/00007890-199405820-00007 · Cited by 219
Angiotensin II blockade decreases TGF-β1 and matrix proteins in cyclosporine nephropathy
Shihab, F. S., Bennett, W. M., Tanner, A. M., & Andoh, T. F. (1997) · Kidney International · doi:10.1038/ki.1997.380 · Cited by 209
Ruiz-Ortega, M., & Egido, J. (1997) · Kidney International · doi:10.1038/ki.1997.480 · Cited by 209
Cyclosporine-Induced Hypertension After Transplantation
TEXTOR, S. C., CANZANELLO, V. J., TALER, S. J., WILSON, D. J., SCHWARTZ, L. L., AUGUSTINE, J. E., RAYMER, J. M., ROMERO, J. C., WIESNER, R. H., KROM, R. A. F., et al. (1994) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65772-3 · Cited by 195
Renal function: the Cinderella of cardiovascular risk profile
Ruilope, L. M., van Veldhuisen, D. J., Ritz, E., & Luscher, T. F. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01627-8 · Cited by 195
OUTCOME OF PATIENTS WITH RENAL INSUFFICIENCY UNDERGOING LIVER OR LIVER-KIDNEY TRANSPLANTATION1,2
Brown, R. S., Lombardero, M., & Lake, J. R. (1996) · Transplantation · doi:10.1097/00007890-199612270-00018 · Cited by 160
Aldosterone as a mediator of progressive renal disease: Pathogenetic and clinical implications
Epstein, M. (2001) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(01)80115-3 · Cited by 158
Limitations of Creatinine in Quantifying the Severity of Cyclosporine-Induced Chronic Nephropathy
Tomlanovich, S. J., Golbetz, H. V., Perlroth, M. G., Stinson, E. B., & Myers, B. D. (1986) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(86)80107-x · Cited by 140
Renal Failure in the Recipients of Nonrenal Solid Organ Transplants
Wilkinson, A. H., & Cohen, D. J. (1999) · Journal of the American Society of Nephrology · doi:10.1681/asn.v1051136 · Cited by 118
Renal Replacement Therapy in Patients with Diabetic Nephropathy, 1980–1985
Brunner, F. P., Brynger, H. O. A., Challah, S., Faßbinder, W., Geerlings, W., Selwood, N. H., Tufveson, G., & Wing, A. J. (1988) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a091710 · Cited by 114
Predictors of renal function following lung or heart-lung transplantation
Ishani, A., Ertürk, Ş., Hertz, M. I., Matas, A. J., Savik, K., & Rosenberg, M. E. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00361.x · Cited by 113
Chronic cyclosporine nephrotoxicity
Andoh, T. F., & Bennett, W. M. (1998) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199805000-00005 · Cited by 111
Barriers to adequate delivery of hemodialysis
Sehgal, A., Snow, R., Singer, M. E., Amini, S., DeOreo, P. B., Mr, S., & Cebul, R. D. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v31.pm9531174 · Cited by 94
Sandborn, W. J., Hay, E. J., Porayko, M. K., Gores, G. J., Steers, J. L., Krom, R. A. F., & Wiesner, R. H. (1994) · Hepatology · doi:10.1002/hep.1840190419 · Cited by 87
CYCLOSPORINE NEPHROTOXICITY IN LUNG TRANSPLANT RECIPIENTS
Zaltzman, J. S., Pei, Y., Maurer, J., Patterson, A. M., & Cattran, D. C. (1992) · Transplantation · doi:10.1097/00007890-199211000-00021 · Cited by 84
Sato, A., Funder, J. W., & Saruta, T. (1999) · American Journal of Hypertension · doi:10.1016/s0895-7061(99)00066-7 · Cited by 82
Early kidney dysfunction post liver transplantation predicts late chronic kidney disease
Velidedeoğlu, E., Bloom, R. D., Crawford, M. D., Desai, N. M., Campos, L., Abt, P. L., Markmann, J. W., Mange, K. C., Olthoff, K. M., Shaked, A. A., et al. (2004) · Transplantation · doi:10.1097/01.tp.0000114609.99558.41 · Cited by 68
The incidence of renal failure in one hundred consecutive heart-lung transplant recipients
Pattison, J. M., Petersen, J., Kuo, P. C., Valantine, V., Robbins, R. C., & Theodore, J. (1995) · American Journal of Kidney Diseases · doi:10.1016/0272-6386(95)90602-9 · Cited by 65
García-García, G., Deddens, J. A., Rey, R. D., First, M. R., Samuels, S. J., Kant, K. S., & Pollak, V. E. (1985) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(85)80129-3 · Cited by 61
The Spectrum of Ciclosporin Nephrotoxicity
Puschett, J. B., Greenberg, A., Holley, J. L., & McCauley, J. (2008) · American Journal of Nephrology · doi:10.1159/000168123 · Cited by 46
Broekroelofs, J., Stegeman, C. A., Navis, G. J., de Haan, J., van der Bij, W., de Boer, W. J., de Zeeuw, D., & de Jong, P. E. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(99)00133-3 · Cited by 39
Nephrotoxicity associated with cyclosporine and FK506.
Klintmalm, G. B. G., & Gonwa, T. A. (1995) · PubMed · Cited by 22
Aldosterone as a Mediator of Progressive Renal Dysfunction: Evolving Perspectives.
Epstein, M. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.573 · Cited by 21
Renal problems after lung transplantation of cystic fibrosis patients
Schindler, R., Radke, C., Paul, K. P., & Frei, U. A. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.7.1324 · Cited by 14
Cited by
Terrault, N. A., Lok, A. S. F., McMahon, B. J., Chang, K., Hwang, J. P., Jonas, M. M., Brown, R. S., Bzowej, N. H., & Wong, J. B. (2018) · Hepatology · doi:10.1002/hep.29800 · Cited by 4,306
Costanzo, M. R., Costanzo, M. R., Dipchand, A., Starling, R., Anderson, A., Chan, M., Desai, S., Fedson, S., Fisher, P., Gonzales-Stawinski, G., et al. (2010) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2010.05.034 · Cited by 1,653
Immunosuppressive Drugs for Kidney Transplantation
Halloran, P. F. (2004) · New England Journal of Medicine · doi:10.1056/nejmra033540 · Cited by 1,555
Calcineurin Inhibitor Nephrotoxicity
Naesens, M., Kuypers, D. R. J., & Sarwal, M. (2009) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04800908 · Cited by 1,489
EASL Clinical Practice Guidelines: Liver transplantation
(2016) · Journal of Hepatology · doi:10.1016/j.jhep.2015.10.006 · Cited by 1,082
Metadata
- Authors
- Ojo, A. O., Held, P. J., Port, F. K., Wolfe, R. A., Leichtman, A. B., Young, E. W., Arndorfer, J., Christensen, L., & Merion, R. M.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-09-04
- Volume
- 349
- Issue
- 10
- Pages
- 931-940
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2134672034
- Cited by
- 2,220
- References
- 48
- FWCI
- 38.60
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.